Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine

Copyright © 2022. Published by Elsevier Inc.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 237(2022) vom: 01. Apr., Seite 108963
1. Verfasser: Wong, Matthew K (VerfasserIn)
Weitere Verfasser: Liu, Jun T, Budylowksi, Patrick, Yue, Feng Yun, Li, Zhijie, Rini, James M, Carlyle, James R, Zia, Amin, Ostrowski, Mario, Martin, Alberto
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Antibodies B cells COVID19 SARS CoV2 Antibodies, Viral Complementarity Determining Regions Spike Glycoprotein, Coronavirus spike protein, SARS-CoV-2 BNT162 Vaccine N38TVC63NU
Beschreibung
Zusammenfassung:Copyright © 2022. Published by Elsevier Inc.
Convalescent coronavirus disease 2019 (COVID-19) subjects who receive BNT162b2 develop robust antibody responses against SARS-CoV-2. However, our understanding of the clonal B cell response pre- and post-vaccination in such individuals is limited. Here we characterized B cell phenotypes and the BCR repertoire after BNT162b2 immunization in two convalescent COVID-19 subjects. BNT162b2 stimulated many B cell clones that were under-represented during SARS-CoV-2 infection. In addition, the vaccine generated B cell clusters with >65% similarity in CDR3 VH and VL region consensus sequences both within and between subjects. This result suggests that the CDR3 region plays a dominant role adjacent to heavy and light chain V/J pairing in the recognition of the SARS-CoV-2 spike protein. Antigen-specific B cell populations with homology to published SARS-CoV-2 antibody sequences from the CoV-AbDab database were observed in both subjects. These results point towards the development of convergent antibody responses against the virus in different individuals
Beschreibung:Date Completed 18.04.2022
Date Revised 05.05.2023
published: Print-Electronic
ErratumIn: Clin Immunol. 2023 Jun;251:109246. - PMID 37147236
Citation Status MEDLINE
ISSN:1521-7035
DOI:10.1016/j.clim.2022.108963